Literature DB >> 10537058

Calcium-dependent cleavage of striatal enriched tyrosine phosphatase (STEP).

T H Nguyen1, S Paul, Y Xu, J W Gurd, P J Lombroso.   

Abstract

Striatal enriched phosphatase (STEP) is a family of protein tyrosine phosphatases enriched within the CNS. A member of this family, STEP61, is a membrane-associated protein located in postsynaptic densities of striatal neurons. In this study, we demonstrate that STEP61, is cleaved into smaller isoforms. To clarify the mechanism of cleavage, STEP61 was transiently expressed in NT2/D1 neuronal precursor cells. Exposure of transfected cells to the calcium ionophore, A23187, or to thapsigargin resulted in the rapid cleavage of STEP61. Pretreatment with the calpain inhibitor, calpeptin, or EGTA prevented proteolysis. One of the cleavage products has a relative molecular mass of 33 kDa (STEP33). A protein with the identical mobility is detected following calpain treatment of STEP61 fusion protein or postsynaptic densities purified from rat striatum. Exposure of primary neuronal cultures to glutamate also led to a significant increase in the concentration of a low molecular weight form of STEP. Taken together, these results suggest that in response to a rapid influx of calcium, STEP61, is proteolytically cleaved by calpain, leading to the release of a smaller isoform. This model may explain the rapid appearance of STEP33 in response to transient hypoxia-ischemia in the brain as cells attempt to counter the increase in tyrosine phosphorylation levels following neuronal insults.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537058

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

1.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

2.  Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.

Authors:  Ana Saavedra; Albert Giralt; Laura Rué; Xavier Xifró; Jian Xu; Zaira Ortega; José J Lucas; Paul J Lombroso; Jordi Alberch; Esther Pérez-Navarro
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

3.  In vitro stretch injury induces time- and severity-dependent alterations of STEP phosphorylation and proteolysis in neurons.

Authors:  Mahlet N Mesfin; Catherine R von Reyn; Rosalind E Mott; Mary E Putt; David F Meaney
Journal:  J Neurotrauma       Date:  2012-06-25       Impact factor: 5.269

Review 4.  Taking STEPs forward to understand fragile X syndrome.

Authors:  Susan M Goebel-Goody; Paul J Lombroso
Journal:  Results Probl Cell Differ       Date:  2012

Review 5.  Synaptic plasticity: one STEP at a time.

Authors:  Steven P Braithwaite; Surojit Paul; Angus C Nairn; Paul J Lombroso
Journal:  Trends Neurosci       Date:  2006-06-30       Impact factor: 13.837

6.  Mechanisms of calpain mediated proteolysis of voltage gated sodium channel α-subunits following in vitro dynamic stretch injury.

Authors:  Catherine R von Reyn; Rosalind E Mott; Robert Siman; Douglas H Smith; David F Meaney
Journal:  J Neurochem       Date:  2012-04-12       Impact factor: 5.372

Review 7.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

8.  The Dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway.

Authors:  S Paul; G L Snyder; H Yokakura; M R Picciotto; A C Nairn; P J Lombroso
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

9.  X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.

Authors:  Michael R Witten; Lisa Wissler; Melanie Snow; Stefan Geschwindner; Jon A Read; Nicholas J Brandon; Angus C Nairn; Paul J Lombroso; Helena Käck; Jonathan A Ellman
Journal:  J Med Chem       Date:  2017-11-08       Impact factor: 7.446

10.  Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP.

Authors:  Jian Xu; Pradeep Kurup; Yongfang Zhang; Susan M Goebel-Goody; Peter H Wu; Ammar H Hawasli; Matthew L Baum; James A Bibb; Paul J Lombroso
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.